Patients can be shielded from the most onerous cost-sharing burdens for specialty drugs while keeping premiums affordable for the entire enrolled population.
Anne Price, BS
Advertisement
Articles by Anne Price, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Andes Hantavirus FAQs: What to Know as Quarantined Cruise Passengers Return Home
2
Rituximab Suppresses Clinical Relapses, MRI Activity in Pediatric MS
3
New Therapies Offer Hope for Vitiligo, an Often Misunderstood and Undertreated Disease
4
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
5